TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014
TCL Archive Edwards’ NIH Pep Talk Sounded Like An Attack On The Cancer Program, But He Says It Wasn’t March 8, 1974